Larvol Delta - Safety-of-Myeloablative-Conditioning-OrcaT-and-Allogeneic-DonorDerived-CD19CD22CAR-Chimeric-Antigen-Receptor-T-Cells-in-Adults-With-Bcell-Acute-Lymphoblastic-Leukemia-ALL

Orca-T - Orca Biosystems

CD22-CAR T-cell therapy - Stanford University, Adaptive Biotech

http://clinicaltrials.gov/ct2/show/NCT05507827

Aug 19, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next